The short version of pentadecapeptide fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-10-16 and is reviewed periodically as new material appears.
Once dissolved, the material is considerably less stable than the dry solid. Aqueous solutions are usually kept cold and used within a short window, and neutral or mildly acidic buffers are preferred over strongly alkaline conditions. Freeze-thaw cycles promote aggregation and loss of material to container surfaces, so dividing a batch into single-use aliquots is standard. Adsorption to plastic and glass can lower the measured concentration, meaning solution strength may need rechecking before an experiment.
Identity and purity are established with complementary methods rather than one test. Reverse-phase high-performance liquid chromatography separates the main peak from deletion sequences and oxidized variants, and its area percentage is the usual purity figure. Mass spectrometry confirms the expected molecular mass and can flag truncations or modifications that chromatography alone might miss. Amino acid analysis and peptide mapping add sequence-level confirmation, while residual counter-ion and water content are measured separately.
A freeze-dried sample is generally the most stable form and is commonly held at minus twenty degrees Celsius or lower for long-term keeping, with brief transfers at room temperature. The solid is hygroscopic, so vials are warmed to ambient temperature before opening to prevent condensation from degrading the contents. Light exposure and repeated temperature cycling are both avoided in routine handling. Storage over a desiccant is a common laboratory practice that limits moisture uptake during repeated access.
BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.
Most published findings come from rodent models, where the peptide has been examined in wound-healing, gastrointestinal-lesion, tendon, and vascular-injury preparations. A smaller number of early human studies have been reported, chiefly in inflammatory bowel conditions, but the public record is short and has not led to marketing approval in the United States or the European Union. Reviewers therefore classify the compound as investigational, and whether animal results carry over to people remains an open question rather than a settled one.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
| Property | Value | Notes |
|---|---|---|
| Dry powder storage | -20 °C or below | Desiccated and protected from light |
| Solution storage | 2-8 °C, short term | Aliquot to avoid freeze-thaw cycling |
| Reconstitution solvent | Water or buffered saline | Near-neutral pH is generally preferred |
| Identity confirmation | Mass spectrometry | Matches expected monoisotopic mass |
| Purity assessment | Reverse-phase HPLC | Reported as main-peak area percentage |
Most published reports describe experiments in rodents rather than in people. These studies examine outcomes in tendons, ligaments, bone, stomach lining, and intestinal tissue. In rat and mouse models, a frequently reported effect is faster healing or reduced damage. Sample sizes are usually small, and a substantial share of the work originates from a small number of research groups. Independent replication is limited, so how far the findings extend to humans remains an open question.
Proposed mechanisms in the literature involve the nitric oxide system, vascular endothelial growth factor signaling, and epidermal growth factor receptor pathways. Some studies report changes in blood vessel formation or in inflammatory mediators, while others describe interactions with nervous tissue. Much of this evidence rests on molecular markers in cultured cells or animal models. Whether the same pathways operate the same way in humans has not been established. Authors therefore tend to describe mechanisms as hypothetical rather than settled.
Direct human evidence is scarce. One trial in ulcerative colitis delivered the compound by enema and produced limited publicly reported results without a clear benefit. The compound is not an approved medicine in most jurisdictions. In many markets it is sold as a research chemical; in others it falls under prescription or controlled categories. Regulators have not confirmed any claimed medical use, and product labels rarely undergo premarket review.
Lyophilized peptide is normally kept at minus twenty degrees Celsius or colder, away from light and moisture. Powder held under those conditions is widely treated as stable for long periods, although published stability studies for this exact sequence are sparse and often come from suppliers rather than independent laboratories. Once dissolved, solutions are generally handled cold and used within a short window, because peptide bonds can hydrolyze over time. Repeated freeze-thaw cycles are usually avoided to limit losses, and exact shelf-life figures depend on the buffer and the concentration involved.
Purity is ordinarily reported as a percentage from reverse-phase high-performance liquid chromatography, where the area of the main peak is compared with the total peak area. Identity is confirmed by mass spectrometry, since the measured mass can be checked against the value calculated from the sequence. Some certificates also include amino acid analysis or sequence confirmation by tandem mass spectrometry. A single purity number does not describe the profile of related impurities, so the underlying chromatogram and spectrum usually carry more information than the headline figure.
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
Physical descriptions in supplier documents and papers usually list the compound as a white to off-white powder. It dissolves readily in water and in common aqueous buffers, and solutions are often prepared fresh before an experiment. Molecular mass near 1419 daltons helps verify identity during mass spectrometry. The powder is somewhat hygroscopic, so moisture exposure can alter the measured mass of a sample. Purity is typically reported as a percentage from chromatographic analysis.
As Deka Yellow, Jasmine wields the D-Knuckle and the D-Stick (ディースティック, Dī Sutikku) jitte, which can combine to form the D-Shot (ディーショット, Dī Shotto) handgun and allow her to perform the Twin Cam Shot (ツインカムショット, Tsuin Kamu Shotto) attack alongside Umeko. Using the SP License, she can perform the Mirage Dimension (ミラージュディメンション, Mirāju Dimenshon) attack. Jasmine is portrayed by Ayumi Kinoshita (木下 あゆ美, Kinoshita Ayumi). As a child, she is portrayed by Risa Asagi (浅黄 理紗, Asagi Risa).
== Technology and AI == In July 2025, Eucalyptus Health announced a partnership with AI healthcare platform Amigo to integrate AI-powered health agents into its telehealth services, including an AI assistant deployed for the Juniper weight management clinic. The AI tools were intended to support functions such as patient triage, care coordination and health coaching alongside clinician-led care. Juniper introduced an AI chatbot, June, to provide automated guidance on topics such as nutrition, medication use, and weight-loss plateaus. Mental-health and psychology experts cautioned that AI use in weight-management services required strong safeguards to avoid risks to vulnerable patients, including those with eating-disorder histories.
Sidestream smoke is smoke which goes into the air directly from a burning cigarette, cigar, or smoking pipe. Sidestream smoke is the main component (around 85%) of second-hand smoke (SHS), also known as Environmental Tobacco Smoke (ETS) or passive smoking. The relative quantity of chemical constituents of sidestream smoke are different from those of directly inhaled ("mainstream") smoke, although their chemical composition is similar. Sidestream smoke has been classified as a Class A carcinogen by the U.S. Environmental Protection Agency.
Sources: en.wikipedia.org
==== Federal and large-scale ==== Several different organizations exist to mitigate and respond to food distribution crises in the United States. Prominent contributors to large-scale food distribution effort in the US include the Federal Emergency Management Agency (FEMA), United States Department of Agriculture (USDA), and Salvation Army. FEMA and the USDA work together during food distribution crises to coordinate the procurement and transportation of nonperishable food, water, and other resources to afflicted areas. The Salvation Army receives federal supplies from FEMA and the USDA, and then works on the local level to distribute necessary goods. All food given to civilians during a crisis is typically distributed at mass emergency feeding stations.
The Colombian conflict (Spanish: Conflicto armado interno de Colombia, lit. 'Colombian internal armed conflict') began on May 27, 1964, and is a low-intensity asymmetric war between the government of Colombia, paramilitary groups, crime syndicates, and far-left guerrilla groups engaged in armed factional hostilities to increase their influence in Colombian territory. Some of the most important international contributors to the Colombian conflict include multinational corporations, the United States, Cuba, and the drug trafficking industry. The conflict is historically rooted in the conflict known as La Violencia, which was triggered by the 1948 assassination of liberal political leader Jorge Eliécer Gaitán and in the aftermath of the anti-communist repression in rural Colombia in the 1960s that led Liberal and Communist militants to re-organize into the Revolutionary Armed Forces of Colombia (FARC). The reasons for fighting vary from group to group. The FARC and other guerrilla movements claim to be fighting for the rights of the impoverished in Colombia to protect them from government violence and to provide social justice through communism. The Colombian government claims to be fighting for order and stability, and to protect the rights and interests of its citizens. The paramilitary groups claim to be reacting to perceived threats by guerrilla movements.
== Collaborative research == In addition to internal research and development activities F. Hoffmann-La Roche is also involved in publicly funded collaborative research projects, with other industrial and academic partners. One example in the area of non-clinical safety assessment is the InnoMed PredTox. The company is expanding its activities in joint research projects within the framework of the Innovative Medicines Initiative of the European Federation of Pharmaceutical Industries and Associations and the European Commission.
Sources: en.wikipedia.org
== Awards and honors == 1985 – Outstanding research, Sigma Xi 1985 – Outstanding research, Florida Academy of Sciences 1986 – Outstanding research, Florida Academy of Sciences 1987 – Richard A. Smith Award, Harvard Medical School
In April 2015, Hardee's announced the opening of its 300th restaurant in the Middle East with longtime franchisee, The Americana Group. In 2015, Nation's Restaurant News ranked Hardee's as the No. 28 foodservice chain by sales in the United States through 2011. Carl's Jr. was ranked at No. 37. Combined sales would rank the two at No. 15. In 2013, QSR listed Hardee's at No. 20 and Carl's Jr. at No. 24; if combined they would have been listed at No. 14. In July 2015, Hardee's announced that it would be offering The All-Natural Burger, which launched at sister-chain Carl's Jr. restaurants in December 2014. As of March 2016, CKE has a total of 3,664 franchised or company-operated restaurants in 44 states and 37 foreign countries and U.S. territories. The Hardee's in Millvale, Pennsylvania closed suddenly on August 25, 2025, after 52 years, marking the withdrawal of Hardee's from Greater Pittsburgh. Hardee's, which had entered Pennsylvania with the Sandy's purchase a year before the Millvale location opened, retains one location in Western Pennsylvania in Waynesburg (near the West Virginia border) while the rest in Pennsylvania are in South Central Pennsylvania. In 2026, Hardee's franchise operator Boddie-Noell announced that a location in Virginia Beach would close and be converted to a concept called Biscuits & Bird that focused on breakfast biscuits and chicken tenders, with the restaurant opening under the new branding in July 2026. On July 9, 2026, Superior Star LLC, a Phoenix-based Hardee's franchisee operating in the Midwest, filed for Chapter 11 bankruptcy protection.
== Taxonomy == The Wagler's pit viper has undergone much taxonomic reclassification over the years and was previously placed in the genus Trimeresurus. However, its distinctly different morphology and venom characteristics set it apart, so that eventually a new genus was erected in which it was placed together with Hutton's viper, Tropidolaemus huttoni.
Sources: en.wikipedia.org
Low temperature slows the chemical reactions, such as oxidation and hydrolysis, that break down a peptide chain. Water and oxygen are the main drivers of degradation, so a cold and dry environment extends usable life. Actual shelf life depends on the batch, the salt form, and the container.
It normally reports the share of the chromatographic signal that belongs to the main peak, not a measure of activity. A high figure means few related substances were detected under the stated method and wavelength. Different laboratories and methods can return different values for the same material.
Retention time alone is weak evidence, because unrelated peptides can elute at similar positions. Amino acid analysis or peptide mapping gives stronger sequence information when a mass spectrometer is unavailable. Most laboratories still treat mass confirmation as the standard step for verifying the correct compound.
It is not approved for human use in the United States or the European Union. Clinical material has been studied in a small number of early trials, mainly for inflammatory bowel conditions, and the compound remains investigational. Regulators treat marketed products as unapproved rather than as authorized drugs.